149 related articles for article (PubMed ID: 26190962)
1. Nitrile as Activating Group in the Asymmetric Bioreduction of β-Cyanoacrylic Acids Catalyzed by Ene-Reductases.
Winkler CK; Clay D; Turrini NG; Lechner H; Kroutil W; Davies S; Debarge S; O'Neill P; Steflik J; Karmilowicz M; Wong JW; Faber K
Adv Synth Catal; 2014 May; 356(8):1878-1882. PubMed ID: 26190962
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic asymmetric synthesis of pregabalin precursors via asymmetric bioreduction of β-cyanoacrylate esters using ene-reductases.
Winkler CK; Clay D; Davies S; O'Neill P; McDaid P; Debarge S; Steflik J; Karmilowicz M; Wong JW; Faber K
J Org Chem; 2013 Feb; 78(4):1525-33. PubMed ID: 23316696
[TBL] [Abstract][Full Text] [Related]
3. A substrate-driven approach to determine reactivities of α,β-unsaturated carboxylic esters towards asymmetric bioreduction.
Tasnádi G; Winkler CK; Clay D; Sultana N; Fabian WM; Hall M; Ditrich K; Faber K
Chemistry; 2012 Aug; 18(33):10362-7. PubMed ID: 22736443
[TBL] [Abstract][Full Text] [Related]
4. An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation.
Burk MJ; De Koning PD; Grote TM; Hoekstra MS; Hoge G; Jennings RA; Kissel WS; Le TV; Lennon IC; Mulhern TA; Ramsden JA; Wade RA
J Org Chem; 2003 Jul; 68(14):5731-4. PubMed ID: 12839471
[TBL] [Abstract][Full Text] [Related]
5. BioLindlar Catalyst: Ene-Reductase-Promoted Selective Bioreduction of Cyanoalkynes to Give (Z)-Cyanoalkenes.
González-Rodríguez J; González-Granda S; Kumar H; Alvizo O; Escot L; Hailes HC; Gotor-Fernández V; Lavandera I
Angew Chem Int Ed Engl; 2024 Jun; ():e202410283. PubMed ID: 38943496
[TBL] [Abstract][Full Text] [Related]
6. Stereoselectivity Switch in the Reduction of α-Alkyl-β-Arylenones by Structure-Guided Designed Variants of the Ene Reductase OYE1.
Crotti M; Parmeggiani F; Ferrandi EE; Gatti FG; Sacchetti A; Riva S; Brenna E; Monti D
Front Bioeng Biotechnol; 2019; 7():89. PubMed ID: 31080798
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Ene-Reduction of α,β-Unsaturated Compounds by F
Kang SW; Antoney J; Frkic RL; Lupton DW; Speight R; Scott C; Jackson CJ
Biochemistry; 2023 Feb; 62(3):873-891. PubMed ID: 36637210
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds.
Winkler CK; Tasnádi G; Clay D; Hall M; Faber K
J Biotechnol; 2012 Dec; 162(4):381-9. PubMed ID: 22498437
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric Reductive Carbocyclization Using Engineered Ene Reductases.
Heckenbichler K; Schweiger A; Brandner LA; Binter A; Toplak M; Macheroux P; Gruber K; Breinbauer R
Angew Chem Int Ed Engl; 2018 Jun; 57(24):7240-7244. PubMed ID: 29689601
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the stereochemical course of ene reductase-catalysed reactions by deuterium labelling.
Brenna E; Fronza G; Fuganti C; Parmeggiani F
Isotopes Environ Health Stud; 2015; 51(1):24-32. PubMed ID: 25675259
[TBL] [Abstract][Full Text] [Related]
11. Enantiomeric Identification of Pregabalin by GC-MS via Methylation and S-TPC Chiral Derivatization.
Hitchcock ML; Marginean I
J Forensic Sci; 2019 Mar; 64(2):406-412. PubMed ID: 30080926
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric Ene-Reduction by F
Kang SW; Antoney J; Lupton DW; Speight R; Scott C; Jackson CJ
Chembiochem; 2023 Apr; 24(8):e202200797. PubMed ID: 36716144
[TBL] [Abstract][Full Text] [Related]
13. Recombinant expression and characterisation of the oxygen-sensitive 2-enoate reductase from Clostridium sporogenes.
Mordaka PM; Hall SJ; Minton N; Stephens G
Microbiology (Reading); 2018 Feb; 164(2):122-132. PubMed ID: 29111967
[TBL] [Abstract][Full Text] [Related]
14. Overcoming co-product inhibition in the nicotinamide independent asymmetric bioreduction of activated C=C-bonds using flavin-dependent ene-reductases.
Winkler CK; Clay D; van Heerden E; Faber K
Biotechnol Bioeng; 2013 Dec; 110(12):3085-92. PubMed ID: 23794404
[TBL] [Abstract][Full Text] [Related]
15. Efficient Biocatalytic Synthesis of Chiral Intermediate of Pregabalin Using Immobilized
Ding X; Tang XL; Zheng RC; Zheng YG
Biomed Res Int; 2018; 2018():6192059. PubMed ID: 30515409
[TBL] [Abstract][Full Text] [Related]
16. Design and application of a bi-functional redox biocatalyst through covalent co-immobilization of ene-reductase and glucose dehydrogenase.
Nagy F; Gyujto I; Tasnádi G; Barna B; Balogh-Weiser D; Faber K; Poppe L; Hall M
J Biotechnol; 2020 Nov; 323():246-253. PubMed ID: 32891641
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric bioreduction of alkenes using ene-reductases YersER and KYE1 and effects of organic solvents.
Yanto Y; Winkler CK; Lohr S; Hall M; Faber K; Bommarius AS
Org Lett; 2011 May; 13(10):2540-3. PubMed ID: 21510626
[TBL] [Abstract][Full Text] [Related]
18. CAL-B catalyzed desymmetrization of 3-alkylglutarate: "olefin effect" and asymmetric synthesis of pregabalin.
Jung JH; Yoon DH; Kang P; Lee WK; Eum H; Ha HJ
Org Biomol Chem; 2013 Jun; 11(22):3635-41. PubMed ID: 23525234
[TBL] [Abstract][Full Text] [Related]
19. Optimization of asymmetric reduction conditions of 2-bromo-1-(naphthalen-2-yl)ethanone by Enterococcus faecium BY48 biocatalyst with A-optimal design-embedded model.
Özdemir A; Şahin E
Chirality; 2022 May; 34(5):796-806. PubMed ID: 35218076
[TBL] [Abstract][Full Text] [Related]
20. Stereocomplementary bioreduction of alpha,beta-unsaturated dicarboxylic acids and dimethyl esters using enoate reductases: enzyme- and substrate-based stereocontrol.
Stueckler C; Hall M; Ehammer H; Pointner E; Kroutil W; Macheroux P; Faber K
Org Lett; 2007 Dec; 9(26):5409-11. PubMed ID: 18031047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
